T cells in multiple sclerosis and experimental autoimmune encephalomyelitis.
about
Multiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormoneSignal pathways in astrocytes activated by cross-talk between of astrocytes and mast cells through CD40-CD40LImpact of Exercise on Innate Immunity in Multiple Sclerosis Progression and SymptomatologyMonoclonal antibody therapies for the treatment of relapsing-remitting multiple sclerosis: differentiating mechanisms and clinical outcomesFollicular Helper CD4+ T Cells in Human Neuroautoimmune Diseases and Their Animal ModelsBrain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid systemRole of microglia in CNS autoimmunityMultiple sclerosis: the role of cytokines in pathogenesis and in therapiesThe dopaminergic system in autoimmune diseasesA herpes simplex virus-derived replicative vector expressing LIF limits experimental demyelinating disease and modulates autoimmunityNormal Development and Function of T Cells in Proline Rich 7 (Prr7) Deficient MiceThe experimental autoimmune encephalomyelitis disease course is modulated by nicotine and other cigarette smoke componentsMultiple Sclerosis and T Lymphocytes: An Entangled StoryThe mechanism of action of interferon-β in relapsing multiple sclerosisImmune heterogeneity in neuroinflammation: dendritic cells in the brainAmelioration of experimental autoimmune encephalomyelitis by plumbagin through down-regulation of JAK-STAT and NF-κB signaling pathwaysQuetiapine, an atypical antipsychotic, is protective against autoimmune-mediated demyelination by inhibiting effector T cell proliferationChloroquine treatment enhances regulatory T cells and reduces the severity of experimental autoimmune encephalomyelitisIL7Rα expression and upregulation by IFNβ in dendritic cell subsets is haplotype-dependentA cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitisChemical proteomic map of dimethyl fumarate-sensitive cysteines in primary human T cellsThe far-reaching scope of neuroinflammation after traumatic brain injury.Circulating immune cells in multiple sclerosis.Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis.Intracranial delivery of interleukin-17A via adeno-associated virus fails to induce physical and learning disabilities and neuroinflammation in mice but improves glucose metabolism through AKT signaling pathwayHuman Adipose Stromal/Stem Cells from Obese Donors Show Reduced Efficacy in Halting Disease Progression in the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis.Tuftsin-driven experimental autoimmune encephalomyelitis recovery requires neuropilin-1.In vivo modification of tRNA with an artificial nucleobase leads to full disease remission in an animal model of multiple sclerosis.Helminth Immunomodulation in Autoimmune Disease.Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitis.Constitutive expression of murine c-FLIPR causes autoimmunity in aged miceApolipoprotein E mediation of neuro-inflammation in a murine model of multiple sclerosis.A comparative study of experimental mouse models of central nervous system demyelination.Galectin-8 as an immunosuppressor in experimental autoimmune encephalomyelitis and a target of human early prognostic antibodies in multiple sclerosis.Deficiency of the G protein Gαq ameliorates experimental autoimmune encephalomyelitis with impaired DC-derived IL-6 production and Th17 differentiationLow-dose 5-aza-2'-deoxycytidine pretreatment inhibits experimental autoimmune encephalomyelitis by induction of regulatory T cellsIncrease in Th17 and T-reg lymphocytes and decrease of IL22 correlate with the recovery phase of acute EAE in rat.Both positive and negative effects on immune responses by expression of a second class II MHC molecule.The effect of omeprazole on the development of experimental autoimmune encephalomyelitis in C57BL/6J and SJL/J mice.Myelin oligodendrocyte glycoprotein (MOG35-55) induced experimental autoimmune encephalomyelitis (EAE) in C57BL/6 mice
P2860
Q21558407-3D0F1B84-82EB-4BDF-9BA0-56679422CAE6Q24297472-B2BCCA0D-A569-46F7-B0DB-32E3A78BB8C5Q26745562-62CEFB82-FA83-4B00-A925-2269AF12479CQ26776234-C0D80D60-8F82-4F4B-BA37-BFE3236A2C01Q26795577-71323DEC-1FF4-43DF-B0C8-73AFF227BC31Q26865295-01E77C9C-8EE2-4356-809A-DE1C7AD0F69DQ27003940-CBC6F6B8-8DDB-43F6-AD18-E7D9FC21D2D9Q27011014-E3A5847C-316F-438D-B620-7D75B77751ACQ27023885-AB1BB614-3878-493B-AF39-871CAE9C1684Q27319470-9BF6F46D-8566-41C8-AB23-53D0CDE0AD7BQ27322365-59BA2E92-8835-4009-A8F3-67ACE3AE63C9Q27346351-1E2DF182-73C6-41DB-9CD3-A0A7C399C028Q28086853-C9ED70A2-E492-46DE-8D35-06B3CE83A70CQ28239752-A62F9C0A-DA3C-48A7-BAFB-0830404B55D1Q28385127-3006C27C-5011-4F69-AEB7-39DA6012264CQ28477723-3B15D2C5-7675-4EC6-ADFC-4B45DD0820F3Q28482227-ACD93FCC-BAD1-46F9-A89B-2A7C15D000AEQ28533957-BE484D91-04C0-47E9-937D-938C0193A170Q28534445-0FF61BCA-B564-4E73-A6D6-2B19AB59541FQ28537808-ECEC91C7-F7ED-443D-B0FD-AB0564B97A2EQ28821775-E56CF5E5-B23D-4C3E-8F95-8FF05F016208Q30235977-77496D4D-68E2-4FC8-817B-F14B652D4F7BQ30242026-D47AAAAF-1E22-48BF-AFC2-FAACF3288581Q30690412-A9737161-32DB-473A-98CE-54F30BCC469DQ30724821-C7AD394C-7B1E-498F-8C5A-8E14777F3719Q30731580-CB9E3E86-D53F-491A-9D96-1A60B0F6F211Q30743356-1B934EE6-21AD-470A-94BF-06DB9D99FD90Q33558399-5891E160-68F3-4C43-8888-7DA94D1D345BQ33593313-760DDE28-20F1-4087-B3DE-2B8CA121BE3BQ33653403-608E6510-0735-41C8-9479-53D6DC9803BDQ33654218-97C54992-1819-49FD-9890-946D16F61451Q33702321-73D8AEE5-87B2-4BA9-BA56-20BE9760D033Q33717475-E5A8D4D4-25DD-4F8D-BBD1-D0D0E450B7C4Q33834605-11098265-BA74-4166-B1FC-689249FC36ADQ33920152-1AE88DB2-8464-4FBB-B230-0A705D9D7828Q33934590-25F521BF-E424-4FA6-9C42-56C008029EFFQ34081554-FE62A776-39DA-4E5A-9F4C-2B72014347A5Q34146648-E5765B52-A740-4ADD-8FDC-4BC8B58F44A1Q34203715-2BA5C98D-5405-42EC-A1D4-9EFA00A4A542Q34229593-0222CDF0-B018-458A-90B1-8A05F236FC00
P2860
T cells in multiple sclerosis and experimental autoimmune encephalomyelitis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
T cells in multiple sclerosis and experimental autoimmune encephalomyelitis.
@en
T cells in multiple sclerosis and experimental autoimmune encephalomyelitis.
@nl
type
label
T cells in multiple sclerosis and experimental autoimmune encephalomyelitis.
@en
T cells in multiple sclerosis and experimental autoimmune encephalomyelitis.
@nl
prefLabel
T cells in multiple sclerosis and experimental autoimmune encephalomyelitis.
@en
T cells in multiple sclerosis and experimental autoimmune encephalomyelitis.
@nl
P2860
P50
P1476
T cells in multiple sclerosis and experimental autoimmune encephalomyelitis
@en
P2093
C M Sweeney
P2860
P356
10.1111/J.1365-2249.2010.04143.X
P577
2010-10-01T00:00:00Z